Injective vs Kinetiq
Compare Injective and Kinetiq on TVL, fees, revenue and activity to understand how these projects stack up.
Injective Perps is the perpetual futures market of Injective, a layer 1 blockchain optimized for finance. Trading runs on Injective's native onchain order book module, which offers fully onchain matching and settlement, front-running resistance through frequent batch auctions and very low fees. Markets cover major crypto assets as well as real-world assets such as equities, commodities and forex, and the shared liquidity layer is used by multiple trading front-ends built on Injective. Part of the fees feeds the INJ burn auction.
View Full Page$900.76M
Kinetiq is a non-custodial liquid staking protocol built natively on Hyperliquid L1. Users stake HYPE and receive kHYPE, a liquid, yield-accruing representation usable across the Hyperliquid DeFi ecosystem. Behind the scenes, StakeHub — Kinetiq’s autonomous validator scoring and delegation system — routes stake to the highest-performing validators to maximise yield and reinforce network security. kHYPE grows in value automatically through validator rewards, requires no claiming, and remains fully composable for lending, liquidity provision and advanced yield strategies. Kinetiq’s architecture emphasises security through multi-layered safeguards, multiple independent audits and a $5M bug bounty. The protocol also offers iHYPE, a compliant, institution-ready staking solution. With over a billion dollars staked, Kinetiq powers scalable, efficient and integrated liquid staking for the entire Hyperliquid ecosystem.
View Full PageKey Metrics Comparison
Injective
TVLN/A
24h Volume$4.43M
24h FeesN/A
24h RevenueN/A
30d FeesN/A
30d RevenueN/A
7d TVL ChangeN/A
Dominance0.00%
Kinetiq
TVL$900.76M
24h Volume$1.75M
24h Fees$49.6K
24h Revenue$4.8K
30d Fees$1.7M
30d Revenue$183.9K
7d TVL Change-5.82%
Dominance1.00%
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
TVL Share
Share of combined TVL
Injective
1.0%Kinetiq
1.0%Volume Share
Share of combined 24h volume
Injective
71.6%Kinetiq
28.4%Fees Share
Share of combined 24h fees
Injective
1.0%Kinetiq
1.0%Revenue Share
Share of combined 24h revenue
Injective
1.0%Kinetiq
1.0%7d TVL Performance
TVL change over last 7 days
Injective
N/AKinetiq
-5.82%Dominance
Market dominance by TVL
Injective
0.0%Kinetiq
1.0%